Aethlon Medical, Inc. Presented as Sole Developer of Viral Filtration Systems to Combat Against Biological Weapons
April 1, 2004 (Press Release) --
Bioterrorism Stated as a Major Concern at Homeland Security Investment Conference - Aethlon Medical, Inc. Presented as Sole Developer of Viral Filtration Systems to Combat Against Biological Weapons
homelanddefensestocks.com is pleased to announce that the March 30th Investment Opportunities in Homeland Defense and Security Conference presentation for Aethlon Medical, Inc. is available in PowerPoint and will be available in audio next week for investors and industry to review. Aethlon Medical, Inc. (OTCBB: AEMD) was one of twelve public companies and five industry speakers that educated investors, media and industry analysts at the conference on the long-term prospects and potential of the homeland security industry. Aethlon was the only public company in the group addressing bioterrorism, the number one concern of industry experts.
Full Details at http://www.investorideas.com/Companies/ViewDocument.asp?ID=1772
homelanddefensestocks.com is pleased to announce that the March 30th Investment Opportunities in Homeland Defense and Security Conference presentation for Aethlon Medical, Inc. is available in PowerPoint and will be available in audio next week for investors and industry to review. Aethlon Medical, Inc. (OTCBB: AEMD) was one of twelve public companies and five industry speakers that educated investors, media and industry analysts at the conference on the long-term prospects and potential of the homeland security industry. Aethlon was the only public company in the group addressing bioterrorism, the number one concern of industry experts.
Full Details at http://www.investorideas.com/Companies/ViewDocument.asp?ID=1772
Email
Print
SPAM
